Doyle Anthony
Insider CIK 1808688 · BCRX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-12-19 | 2024-12-23 | 250,100 | — | $0 | 250,100 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-12-19 | 2024-12-23 | 2,461 | $7.39 | $18.2K | 377,867 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-12-19 | 2024-12-23 | 120,700 | — | $0 | 380,328 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-12-14 | 2024-12-17 | 7,890 | $7.53 | $59.4K | 259,628 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2024-05-14 | 2024-05-15 | 36,300 | $5.57 | $202.2K | 266,744 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2023-12-19 | 2023-12-20 | 2,482 | $6.05 | $15.0K | 227,444 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-12-14 | 2023-12-18 | 158,500 | — | $0 | 158,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2023-12-14 | 2023-12-18 | 5,475 | $6.43 | $35.2K | 229,926 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-12-14 | 2023-12-18 | 34,000 | — | $0 | 235,401 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-12-19 | 2022-12-21 | 158,500 | — | $0 | 158,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-12-19 | 2022-12-21 | 34,000 | — | $0 | 197,966 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-12-15 | 2022-12-19 | 5,700 | $10.90 | $62.1K | 163,966 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-12-14 | 2022-01-13 | 75,000 | — | $0 | 168,719 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-12-14 | 2021-12-16 | 164,000 | — | $0 | 164,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-12-14 | 2021-12-16 | 115,000 | — | $0 | 208,719 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2021-11-23 | 2021-11-24 | 35,258 | $12.48 | $440.0K | 93,719 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-15 | 2020-12-17 | 332,500 | — | $0 | 332,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2020-08-11 | 2020-08-12 | 54,000 | $4.08 | $220.3K | 54,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-04-30 | 2020-05-04 | 600,000 | — | $0 | 600,000 | SEC↗ |